Clinical Trials in Surabaya, Indonesia
Locations / Surabaya, Indonesia
Delta Trials hosts 124 clinical trials conducted in Surabaya, Indonesia, making it a notable site of clinical research activity. These trials covering 154 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 7 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Surabaya.
124
Total Trials
154
Conditions
7
Terminated since 2020
Browse by condition (154 total)
- Covid-19 pandemic 6 trialsAll Covid-19 pandemic trials
- Hypertension 5 trialsAll Hypertension trials
- Covid-19 vaccines 5 trialsAll Covid-19 vaccines trials
- Type 2 diabetes mellitus 3 trialsAll Type 2 diabetes mellitus trials
- COVID-19 3 trialsAll COVID-19 trials
- HIV infections 3 trialsAll HIV infections trials
- Obesity 3 trialsAll Obesity trials
- Dementia 3 trialsAll Dementia trials
- Hypercholesterolemia 2 trialsAll Hypercholesterolemia trials
- Overactive bladder 2 trialsAll Overactive bladder trials
- Safety issues 2 trialsAll Safety issues trials
- Coronary artery disease 2 trialsAll Coronary artery disease trials
- Failure to thrive 2 trialsAll Failure to thrive trials
- Growth faltering 2 trialsAll Growth faltering trials
- Diet, healthy 2 trialsAll Diet, healthy trials
- Insulin resistance 2 trialsAll Insulin resistance trials
- Non-small cell lung cancer 2 trialsAll Non-small cell lung cancer trials
- Pregnant women 2 trialsAll Pregnant women trials
- Venous thromboembolism 2 trialsAll Venous thromboembolism trials
- Acute ischemic stroke 2 trialsAll Acute ischemic stroke trials